Target intelligence / Profile preview

Ribosomal protein L23a pseudogene 76 (RPL23AP76)

Target
RPL23AP76
Molecular classification
Other (processed pseudogene)
01

Overview

RPL23AP76 is a processed pseudogene derived from the ribosomal protein L23a (RPL23A) gene family[3][8]. Pseudogenes are segments of DNA similar to known genes but typically lack the ability to produce functional proteins due to mutations or loss of essential regulatory elements. RPL23AP76 is located on chromosome 14 (GRCh37: 14,851,058–14,851,515)[8]. While ribosomal proteins and their pseudogenes may be found throughout the genome, and some pseudogenes might have regulatory or evolutionary roles, there is no evidence that RPL23AP76 has any functional, diagnostic, or therapeutic importance in humans. It is not an enzyme, receptor, transporter, ion channel, or typical drug target. No phenotypic, disease, or clinical associations are attributed to this specific pseudogene in the literature or databases[3][6][8].

Other names
RPL23A_31_1517RPL23AP76
02

Biological functions

Other (pseudogenes are generally defined as non-functional gene copies; no confirmed biological function for RPL23AP76 itself in protein synthesis or regulation)
03

Disease associations

Other (no established role in disease; specific functional impact not described in literature or major databases for RPL23AP76)

Beyond the preview

Go deeper on Ribosomal protein L23a pseudogene 76 (RPL23AP76).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L23a pseudogene 76 (RPL23AP76).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call